Nordion Inc (NDN.TO)

BUY
May have a tough year. A few of their divisions having pricing pressures. Likes their position in health care.
TOP PICK
Good cash flow from labs. Historically has grown 15%. Probably down in 2001 but good long term stock.
DON'T BUY
Expect earnings to drop. Use stop losses.
BUY
In a good sector. Likes.
PAST TOP PICK
(Was a top pick on Dec 24 down 36%) Down because of proteomic concerns. This will pass. At a good price. Still buying.
BUY
Very volatile, but price is good for long term hold.
TOP PICK
Bullet proof portfolio-large caps (40%) Has buy orders in at $18.50/19 In a DIP position now. An 18/20% growth company. Good cash flow.
STRONG BUY
Took proteomics off the IPO because of weak market. Stock is down because of this, but it was a smart move. Will bee good in the long term.
BUY
Good because of diversification.
BUY ON WEAKNESS
Good conservative company but prefers to buy a little cheaper.
PAST TOP PICK
Down, but still likes.
BUY
Excellent. Premier pharmaceutical plays.
BUY
Has good asset mix and is undervalued.
BUY
Into a lot of bio areas and risk is spread out.
WAIT
Proteomics IPO delayed because of market volatility.
Showing 181 to 195 of 229 entries